MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$1,129,385,000
EPS
-$5.95
Unit: Dollar

Income Statement
2025-12-31
Total revenue
0
Research and development
987,332,000
General and administrative
195,037,000
Total operating expenses
1,182,369,000
Loss from operations
-1,182,369,000
Interest income
90,694,000
Interest expense
24,231,000
Change in fair value of warrant liability and contingent earn-out shares
-15,358,000
Other expense, net
37,000
Total non-operating income, net
51,068,000
Income (loss) before provision for income taxes
-1,131,301,000
Benefit from income taxes
0
Net loss
-1,131,301,000
Unrealized gain on investments, net
1,916,000
Comprehensive loss
-1,129,385,000
Basic EPS
-5.95
Diluted EPS
-5.95
Basic Average Shares
190,129,154
Diluted Average Shares
190,129,154
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$1,129,385,000 Unrealized gain oninvestments, net$1,916,000 Net loss-$1,131,301,000 Interest income$90,694,000 Income (loss) beforeprovision for income taxes-$1,131,301,000 Total non-operatingincome, net$51,068,000 Interest expense$24,231,000 Change in fair value ofwarrant liability and...-$15,358,000 Other expense, net$37,000 Loss from operations-$1,182,369,000 Total operatingexpenses$1,182,369,000 Research and development$987,332,000 General andadministrative$195,037,000

Revolution Medicines, Inc. (RVMD)

Revolution Medicines, Inc. (RVMD)